- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 26.08. | Scandinavian Real Heart AB: Interim Report H1 2026 | 144 | GlobeNewswire (Europe) | Summary of Interim Report H1 2026
Group Overview2026-01-012025-01-012025-01-012026-06-302025-06-302025-12-316 mon6 mon12 monOperating income86 58790 586153 098Earnings after financial items-23 960... ► Artikel lesen | |
| SCANDINAVIAN REAL HEART Aktie jetzt für 0€ handeln | |||||
| 20.08. | Scandinavian Real Heart AB: Realheart Sets February 2028 Target to Be Ready for First-in-Human Implantation and Provides Development Update | 170 | GlobeNewswire (Europe) | Västerås - Scandinavian Real Heart AB (publ) today announced that the Company's Board of Directors has adopted a new strategic goal: that the Company shall be ready for the first-in-human implantation... ► Artikel lesen | |
| 28.05. | Scandinavian Real Heart AB: Bulletin from the Annual General Meeting of Scandinavian Real Heart AB on May 28, 2026 | 310 | GlobeNewswire (Europe) | On 28 May 2026, Scandinavian Real Heart AB (the "Company") held its Annual General Meeting (AGM) at which the following resolutions were adopted.
Adoption of the income statement and balance sheet... ► Artikel lesen | |
| 28.05. | Scandinavian Real Heart AB: Realheart Granted Patent Approval in Australia | 241 | GlobeNewswire (Europe) | Västerås, Sweden, June 28, 2026 - Scandinavian Real Heart AB (publ) today announced that IP Australia, the Australian intellectual property rights agency, has granted Realheart a patent covering central... ► Artikel lesen | |
| 21.04. | Scandinavian Real Heart data supports total artificial heart system | 1 | MassDevice | ||
| 04.03. | Scandinavian Real Heart AB: Realheart Receives Patent Approval in India | 368 | GlobeNewswire (Europe) | Västerås, Sweden, March 4 2026 - Scandinavian Real Heart AB (publ) announces today that the company has been granted a patent approval in India. The patent covers a control method and system configuration... ► Artikel lesen | |
| 19.02. | Scandinavian Real Heart AB: Year-End Report H2 2025 | 386 | GlobeNewswire (Europe) | Summary of Year-End Report H2 2025
Group Overview2025-07-012024-07-012025-01-012024-01-012025-12-312024-12-312025-12-312024-12-316 mon6 mon12 mon12 monOperating income62 5129 674153 09850 054Earnings... ► Artikel lesen | |
| 11.02. | Scandinavian Real Heart AB: Realheart Receives Patent Approval in Europe | 330 | GlobeNewswire (Europe) | Västerås, Sweden, February 11, 2026 - Scandinavian Real Heart AB (publ) announces today that the company has been granted patent approval by the European Patent Office (EPO). The patent concerns both... ► Artikel lesen | |
| 28.01. | Scandinavian Real Heart AB: Scandinavian Real Heart AB announces outcome of the Company's rights issue | 393 | GlobeNewswire (Europe) | NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, JAPAN, SOUTH AFRICA OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE OR DISTRIBUTION... ► Artikel lesen | |
| 07.01. | XFRA CAPITAL ADJUSTMENT INFORMATION - 07.01.2026 | 860 | Xetra Newsboard | Das Instrument SFTU US83404D1090 SOFTBANK GR.UNS.ADR1/2/ON EQUITY wird cum Kapitalmassnahme gehandelt am 07.01.2026 und ex Kapitalmassnahme am 08.01.2026 The instrument SFTU US83404D1090 SOFTBANK GR.UNS.ADR1/2/ON... ► Artikel lesen | |
| 16.12.25 | Scandinavian Real Heart AB: Realheart resolves on a rights issue of SEK 70 million | 383 | GlobeNewswire (Europe) | NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, JAPAN, SOUTH AFRICA OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE OR DISTRIBUTION... ► Artikel lesen | |
| 16.12.25 | Scandinavian Real Heart AB: Bulletin from the Extraordinary General Meeting in Scandinavian Real Heart AB (publ) on 16 December 2025 | 265 | GlobeNewswire (Europe) | Scandinavian Real Heart AB (publ) held an Extraordinary General Meeting on December 16, 2025. All decisions were made in accordance with the proposals set out in the notice.
Resolutions at the General... ► Artikel lesen | |
| 27.11.25 | XFRA CAPITAL ADJUSTMENT INFORMATION - 27.11.2025 | 1.341 | Xetra Newsboard | Das Instrument B0M SGXE21011833 ALPINA HOLDINGS EQUITY wird cum Kapitalmassnahme gehandelt am 27.11.2025 und ex Kapitalmassnahme am 28.11.2025 The instrument B0M SGXE21011833 ALPINA HOLDINGS EQUITY... ► Artikel lesen | |
| 05.11.25 | Scandinavian Real Heart AB: Realheart Receives Patent Approvals in Key Asian Markets | 371 | GlobeNewswire (Europe) | Västerås, Sweden, November 5, 2025 - Scandinavian Real Heart AB (publ) announces today that the company has been granted patent approvals in China and Japan. The patents concern both the core technology... ► Artikel lesen | |
| 26.09.25 | Scandinavian Real Heart AB: Realheart Receives Patent Approval in Japan | 494 | GlobeNewswire (Europe) | Västerås, Sweden, September 26, 2025 - Scandinavian Real Heart AB (publ) announces today that the company has been granted patent approval by the Japan Patent Office (JPO) concerning the automatic control... ► Artikel lesen | |
| 17.09.25 | Scandinavian Real Heart AB: Realheart Publishes Positive Blood Flow Data Using a Groundbreaking 4D Medical Imaging Method | 489 | GlobeNewswire (Europe) | Västerås, Sweden, September 17, 2025 - Scandinavian Real Heart AB (publ) announces today that the company and its academic partner at Linköping University has published results from a scientific study... ► Artikel lesen |
16 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| UNITEDHEALTH | 327,80 | +0,31 % | Dividendenbekanntmachungen (14.09.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) BROOKFIELD CORPORATION CA11271J1075 0,07 USD 0,0603 EUR BROOKFIELD WEALTH SOLUTIONS LTD BMG174341047 0,07 USD 0,0603 EUR CHESAPEAKE... ► Artikel lesen | |
| INMODE | 12,915 | +0,39 % | InMode Advances RF Microneedling Comfort with the Launch of Morpheus8 Cool | ||
| SIENNA SENIOR LIVING | 12,600 | +3,28 % | Dividendenbekanntmachungen (31.08.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AGNC INVESTMENT CORP US00123Q1040 0,12 USD 0,1036 EUR AGREE REALTY CORPORATION US0084921008 0,267 USD 0,2305 EUR ALLIED PROPERTIES... ► Artikel lesen | |
| LIFECLEAN INTERNATIONAL | 0,001 | -40,00 % | LifeClean International AB (publ) receives observation status | Today, June 15, 2026, LifeClean International AB (publ) (the "Company") issued a press release with information that the Company's board of directors had resolved to apply for delisting of the Company's... ► Artikel lesen | |
| TENON MEDICAL | 5,850 | 0,00 % | Tenon Medical Announces Warrant Inducement for Aggregate Gross Proceeds of Approximately $2,872,338 | LOS GATOS, CA / ACCESS Newswire / September 11, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a medical device company dedicated to transforming care for patients with certain... ► Artikel lesen | |
| PROGYNY | 27,350 | 0,00 % | Progyny auf Gesundheitskonferenz von Wells Fargo: Wachstumsperspektiven bleiben intakt | ||
| BRIGHTSPRING HEALTH SERVICES | 58,73 | 0,00 % | BTSG Gains More Than 54% YTD: Should You Buy, Hold or Sell? | ||
| LIFESTANCE HEALTH GROUP | 12,975 | 0,00 % | LifeStance Health Group, Inc. - 8-K, Current Report | ||
| HEARTFLOW | 49,850 | 0,00 % | Heartflow, Inc.: Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half | FUSION trial presented at ESC and published in Journal of the American College of Cardiology demonstrates adding non-invasive lesion-specific physiology resolves critical diagnostic uncertainty, supporting... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 12,610 | 0,00 % | Alignment Healthcare USA, LLC: Alignment Health's Fifth Annual Survey Finds Seniors Falling Further Behind: Aging in Place Challenges Continue to Rise as Support Gaps Widen | ||
| FRESENIUS | 45,635 | +0,75 % | UBS stuft Fresenius SE auf 'Buy' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Fresenius mit einem Kursziel von 56 Euro auf "Buy" belassen. Analyst Graham Doyle hält die Sorgen um das US-Geschäft mit... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,500 | -0,13 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 39,120 | -0,49 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 14,060 | 0,00 % | Biotech Stocks At 52-Week Highs - Park Dental Partners +10%, Aveanna Healthcare +24%, Candel Therapeutics +10% on Q2 Reports, Labcorp Holdings, Hemab Therapeutics | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 20,370 | 0,00 % | Oppenheimer reiterates Procept BioRobotics stock rating |
Das Unternehmen SCANDINAVIAN REAL HEART AB kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell -1,69 % bei einem Aktienkurs von 1,450 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SCANDINAVIAN REAL HEART AB finden Sie auf Wallstreet Online.